Gary Titus's Net Worth

$1.27 Million

Estimate Recalculated Sep 13, 2024 08:57PM EST

Who is Gary Titus

Gary Titus has an estimated net worth of $1.27 Million. This is based on reported shares across multiple companies, which include KOSAN BIOSCIENCES INC, NUVELO INC, ImmunoCellular Therapeutics, Ltd., and SCICLONE PHARMACEUTICALS INC.

SEC CIK

Gary Titus's CIK is 0001298900

Past Insider Trading and Trends

2006 was Gary Titus's most active year for acquiring shares with 13 total transactions. Gary Titus's most active month to acquire stocks was the month of July. 2012 was Gary Titus's most active year for disposing of shares, totalling 7 transactions. Gary Titus's most active month to dispose stocks was the month of May. 2011 saw Gary Titus paying a total of $1,045,991.90 for 241,838 shares, this is the most they've acquired in one year. In 2006 Gary Titus cashed out on 75,831 shares for a total of $1,520,862.15, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

KOSAN BIOSCIENCES INC

Sr. VP and CFO
Updated Jun 30, 2008
Form 4
-100.00%
-218.73K
Jun 30, 2008
Disposition
Jun 26
Form 4
5.34%
1.09K
$1.45
$1.59K
Apr 02, 2008
21.53K
Purchase
Mar 31
Form 4
17.47%
3.04K
$1.31
$3.98K
Mar 11, 2008
20.44K
Purchase
Mar 10
Form 4
56.06%
6.25K
$1.57
$9.81K
Mar 06, 2008
17.40K
Purchase
Mar 05
Form 4
32.20K
Jan 04, 2008
32.20K
Grant
Jan 02
Form 4
15.00K
Jan 04, 2007
15.00K
Grant
Jan 02
Form 4
28,571.43%
10.00K
$3.99
$39.93K
Nov 02, 2006
10.04K
Purchase
Oct 31
Form 4
150.00K
Sep 06, 2006
150.00K
Grant
Sep 05
Form 3
Sep 06, 2006
35.00
Showing 9 results

NUVELO INC

Chief Acct.Officer
Updated Aug 31, 2006
Form 4
$11.65
-$253.47K
Aug 31, 2006
2.63K
Sell-Options
Aug 30
Form 4
$14.91
-$78.45K
Aug 30, 2006
2.63K
Sell-Options
Aug 29
Form 4
$14.62
-$425.40K
Aug 28, 2006
2.63K
Sell-Options
Aug 25
Form 4
$14.66
-$145.12K
Aug 25, 2006
2.63K
Sell-Options
Aug 24
Form 4
856.77%
30.60K
$13.61
$507.06K
Aug 02, 2006
34.18K
Acquisition
Aug 31 - Aug 01
Form 4
125.33K
$6.45
$2.10K
Aug 03, 2005
125.33K
Acq/Dis
Feb 28 - Aug 01
Form 4
673.25%
1.64K
$7.52
$12.31K
Feb 24, 2005
1.88K
Purchase
Nov 30 - Feb 23
Form 4
50.00K
Jan 11, 2005
50.00K
Grant
Jan 07
Form 4
40.00K
Sep 15, 2004
40.00K
Grant
Sep 14
Form 3
Jul 29, 2004
243.00
Showing 10 results

ImmunoCellular Therapeutics, Ltd.

Chairman and Secretary
Updated Jun 21, 2016
Form 4
156.75K
Jun 21, 2016
156.75K
Grant
Jun 17
Form 4
111.11%
20.00K
Sep 22, 2015
38.00K
Grant
Sep 18
Form 4
75.00K
Jun 30, 2015
75.00K
Grant
Jun 26
Form 4
47.50K
Jun 17, 2014
47.50K
Grant
Jun 13
Form 4
18.00K
$0.78
$14.04K
Dec 20, 2013
18.00K
Purchase
Dec 20
Form 4
65.00K
Sep 24, 2013
65.00K
Grant
Sep 20
Form 4
-50.00%
-33.29K
Mar 11, 2013
33.29K
Grant
Mar 07
Form 3
Jan 03, 2013
Showing 8 results

SCICLONE PHARMACEUTICALS INC

Senior VP Finance & CFO
Updated Jun 18, 2012
Form 4
-43.54%
-81.35K
$3.98
-$492.81K
Jun 18, 2012
105.49K
Sale
May 31 - Jun 15
Form 4
May 16, 2012
64.90K
Options
May 14
Form 4
563.07%
150.71K
$3.85
$2.73K
Apr 04, 2012
177.48K
Purchase
Aug 31 - Mar 15
Form 4
4.18%
1.07K
$4.65
$5.00K
Aug 18, 2011
26.77K
Purchase
Aug 18
Form 4
10.57%
2.46K
$4.81
$11.82K
Jun 16, 2011
25.69K
Purchase
May 31 - Jun 15
Form 4
37.43K
May 31, 2011
37.43K
Grant
May 27
Form 4
908.98%
201.11K
$3.83
$1.03M
May 16, 2011
223.24K
Purchase
Aug 31 - May 12
Form 4
12.74%
2.50K
$3.39
$8.48K
May 12, 2010
22.13K
Purchase
May 11
Form 4
100.00K
Mar 09, 2010
100.00K
Grant
Mar 05
Form 4
30.83%
4.63K
$1.74
$8.03K
May 26, 2009
19.63K
Purchase
May 22
Form 4
150.00K
Dec 18, 2008
150.00K
Grant
Dec 16
Form 4
15.00K
$1.01
$15.18K
Dec 12, 2008
15.00K
Purchase
Dec 11 - Dec 12
Form 3
Dec 10, 2008
Showing 13 results